Fitzsimon_menu

Filter by

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond
News | Apr 21, 2025

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond

Each quarter the Colorado Real Estate Journal publishes its Healthcare and Life Sciences Quarterly to report on the state of commercial real estate in Colorado. The most recent edition includes an article from Fitzsimons and our leasing partners at CBRE to explore the forecast for life sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum
News | Apr 16, 2025

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum

Aurora's Fitzsimons Innovation Community is saving lives, literally! It's home to all kinds of cutting-edge life science companies that are coming up with ways to improve medical technology and patient care. AuroraTV talks with Fitzsimons' new President and CEO, Kelly Brough, about what lies ahead.

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows
News | Apr 14, 2025

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows

Melissa Krebs, Ph.D., CEO and Founder of Community member GelSana, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. ​This prestigious honor recognizes her pioneering advancements in cell-interactive biomaterials and their clinical translation, particularly in regenerative medicine and drug delivery technologies. Her innovative work is making significant strides in improving patient outcomes and quality of life.

RefinedScience Completes Office and Lab Buildout
News | Apr 07, 2025

RefinedScience Completes Office and Lab Buildout

BNBuilders announced the completion of a new 5,500-square-foot office and lab space for RefinedScience at the Fitzsimons Innovation Community Campus. This modern, functional environment is designed to support scientific innovation and enhance collaboration.

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial
News | Apr 03, 2025

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial

This Phase 3b trial suggests that semaglutide 1.0 mg (Ozempic) could become the first therapy in nearly 20 years to gain regulatory approval for improving functional outcomes in patients with peripheral artery disease (PAD) and type 2 diabetes (T2D). sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora coffee shop offers job training for people experiencing homelessness
News | Apr 02, 2025

Aurora coffee shop offers job training for people experiencing homelessness

Change Please Coffee at Fitzsimons Innovation Community in Aurora is a coffee shop that is doing good in the community by helping people get back on their feet.

RheumaGen:Tackling Autoimmune Disease with Cell and Gene Therapy
News | Apr 01, 2025

RheumaGen:Tackling Autoimmune Disease with Cell and Gene Therapy

Inside Precision Medicine recently highlighted Community member RheumaGen's mission to develop one-time, curative CGT treatments for autoimmune diseases. Read more about their innovative approach and hear from Co-founder and CEO, Richard Freed.

Denver Life Sciences Real Estate Shows Signs Of Improvement
News | Feb 26, 2025

Denver Life Sciences Real Estate Shows Signs Of Improvement

Challenges in the Denver-Boulder life sciences real estate market have leveled off with a spike in leasing activity and venture capital funding to local companies at the end of 2024.

CU Anschutz Debuts New Ad Campaign: Where Dreams Live
News | Feb 24, 2025

CU Anschutz Debuts New Ad Campaign: Where Dreams Live

On Sunday, Feb. 9, during the Super Bowl, CU Anschutz returned to televisions and airwaves across the Denver metro area with a vibrant new marketing campaign. Titled Where Dreams Live, the campaign presents an imaginative take on the spirit of innovation that powers the people and life-changing work taking place on our campus every day.

University of Colorado Anschutz Medical Campus Earns Prestigious R1 Research Classification
News | Feb 18, 2025

University of Colorado Anschutz Medical Campus Earns Prestigious R1 Research Classification

The University of Colorado Anschutz Medical Campus was once again recognized as an R1 institution by the Carnegie Classification of Institutions of Higher Education, a designation shared with the University of Colorado Denver that places it among the nation’s most elite research institutions. This recognition underscores CU Anschutz’s status as a leader in transformative research, innovation and academic excellence.

BIO President and CEO John Crowley Discusses Future of Biotechnology
News | Feb 10, 2025

BIO President and CEO John Crowley Discusses Future of Biotechnology

John Crowley, President and CEO of BIO, visited Colorado as part of the BIO on the American Road listening tour. After a visit to Fitzsimons Innovation Community and the labs at ClinImmune and RheumaGen, Crowley sat down for a conversation with Denver’s KOA Radio. They discussed the future of biotechnology and the value of Colorado’s academic research institutions in advancing life sciences.

CBRE Reports Examine Life Sciences Market
News | Feb 05, 2025

CBRE Reports Examine Life Sciences Market

The U.S. life sciences real estate market posted positive net absorption in the fourth quarter even as robust construction completions raised the sector’s vacancy rate to 19.7%, according CBRE’s new quarterly figures report. The Q4 numbers indicate gradual improvement across the 13 largest U.S. life sciences markets (including Denver-Boulder) and the potential for that momentum to carry through to this year.